Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $5.58
- As of
Kresmion compiles this page from SHPH's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-06.
See the full SHPH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SHPH on one page. Preview it with sample data, then open it live with a free account.
Preview the SHPH dossierActive events for SHPH
No recent events on SHPH in the last 180 days.
FREE, NO ACCOUNT
Every event on SHPH, as it fires
New filings, 13F moves and cross asset events on SHPH land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
SHPH positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| CITADEL ADVISORS LLC FundCUSIP 825693500 · 2026Q2 | $79K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, SHPH
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
SHPH's 10-Q filed Sep 24, 2026 states:
These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on SHPH
SHPH against its peers
SHPH's return on equity of -519.9% ranks in the 4th percentile of 12 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | SHPH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 33.7M | n/a | 16 |
| Gross margin | n/a | 45.6% | n/a | 11 |
| Operating margin | n/a | -12.6% | n/a | 12 |
| Net margin | n/a | -21.8% | n/a | 14 |
| Return on equity | -519.9% | -21.0% | 4 | 12 |
Peers (17): CPHI, ETST, BIOE, MRMD, PLNH, ITHUF, IXHL, INIS, HYEX, TXMD, AYTU, RAPH, RMTI, CXXIF, SCYX, LEEEF, BFRI. Left out: MCUJF (period gap), ROMJF (no annual filing), HSTI (period gap), CPIVF (no annual filing), OPTH (no annual filing), CYPA (no annual filing), INCR (period gap), AKAN (period gap). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (SHPH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in SHPH on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on SHPH in the last 180 days.
Upstream: SEC EDGAR filings for SHPH
Kresmion, "Shuttle Pharmaceuticals Holdings, Inc. (SHPH) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/SHPH. Upstream data: SEC EDGAR filings for SHPH.
Link to this data (HTML):
<a href="https://kresmion.com/research/SHPH">Shuttle Pharmaceuticals Holdings, Inc. (SHPH) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow SHPH on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to SHPH for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.